rcca-header
Clinical Trials

A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

Type of Cancer
Gastrointestinal
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.